Past grants and awards

Ovarian cancer research partnership with CIHR

Operating grant competitions are held annually by CIHR (Canadian Institutes of Health Research), which is the Government of Canada’s health research investment agency. In partnership with CIHR, Ovarian Cancer Canada provided funding to the highest ranking, but unfunded, projects focused on ovarian cancer. This enabled initiation and/or continuation of research until related funding applications could be resubmitted.

Ovarian Cancer Canada provided one year funding of $100,000 to each of the following:

2008/2009 – Dr. Trevor Shepherd, University of Western Ontario. Implications of activated BMP signalling and Id1/Id3 function in ovarian cancer pathogenesis.
2008/2009 – Dr. Gervais Berube, Université du Québec à Trois-Rivières. In vivo evaluation of new anticancer agents for site-specific treatment of breast and ovarian cancers.
2010/2011 - Dr. Jim Petrik, University of Guelph Ontario Veterinary College and McMaster University Department of Obstetrics and Gynecology. Use of Thrombospondin-1 (TSP-1) to destroy abnormal and immature tumour blood vessels while leaving healthy blood vessels unchanged.
2010/2011 - Dr. Barbara Vanderhyden, Ottawa Hospital Research Institute. Role of Sca1+ ovarian surface epithelial cells in ovulatory wound repair.
2011/2012 - Dr. Catherine Classen, Women’s College Hospital, Toronto. A randomized controlled trial of an online support group for sexual distress due to gynecologic cancer.
2011/2012 - Dr. Joanne Kotsopoulos, Women’s College Hospital, Toronto. Evaluating whether telomere length is related to various clinical or pathological features of an ovarian tumour.

Fellowship in partnership with OvCaRe at BC Cancer Agency

A collaboration between the BC Cancer Agency, the Vancouver Coastal Health Research Institute, and the University of British Columbia; OvCaRe proved that ovarian cancer is not one disease but several diseases that respond differently to treatment. This discovery demonstrated potential for targeted treatments and it is already impacting clinical decisions.

OvCaRe aims to improve the lives of women with ovarian cancer and those who are at risk for developing the disease. In support of this, Ovarian Cancer Canada provided a one-time grant of $50,000 for a research fellowship for Dr. Blaise Clark.

Gynecological Cancer Research Awards

Between 1999 and 2002, Ovarian Cancer Canada, in partnership with other Ontario agencies, supported training and career awards for basic, translational, clinical and health services research focused on ovarian and other gynecological cancers. Three-year grants were provided to trainees in clinical disciplines, supporting their studies under the mentorship of a senior investigator who had an international reputation for research excellence.

Fellowship Award

This award was provided to a student in 1998 as part of an initiative with the Genesis Research Foundation.